Doximity Stock Slides on Earnings; Leadership Changes Mount
NEW YORK, May 30 —
Doximity's fiscal fourth-quarter earnings, filed in an 8-K on May 13, 2026, produced a roughly 10% single-session stock decline and arrived alongside a second officer-change disclosure in six weeks. The company's CFO seat remains in interim hands, with no permanent appointment disclosed in either filing. Two days after the report, CEO Jeffrey Tangney collected a 322,614-share equity grant with the stock trading near $18, a price well below where two insiders had sold in the days before the earnings release.
- A director sold 9,000 shares at $26.06 on May 7, and the interim CFO sold 2,309 shares at $25.77 on May 11, both before the post-earnings decline to around $18
- Net open-market insider purchases over the prior 90 days: zero. Net sales: $520,000
- Three consecutive EPS beats preceded this quarter: $0.36 vs. a $0.31 estimate, $0.45 vs. $0.38, and $0.46 vs. $0.45
The Selling Pattern
The insider transaction record here is clean in the wrong sense. Director Kira Scherer Wampler sold 9,000 shares at $26.06 on May 7, collecting roughly $234,500 before the earnings release. Interim Principal Financial Officer Siddharth Sitaram sold 2,309 shares at $25.77 on May 11, two days before the report, for proceeds of approximately $59,500. Both sellers exited at prices roughly 30% above where the stock printed after earnings. Over the prior 90 days, a review of Form 4 filings shows zero open-market purchases against $520,000 in total sales.
Scheduled Rule 10b5-1 plans, if they existed, would not appear on the face of a Form 4, so the timing alone is not evidence of wrongdoing. But the directional pressure is unambiguous: nobody bought.
Still No CFO
Siddharth Sitaram's Form 4 filings list his title as "Interim Principal Financial Officer and Principal Accounting Officer." That phrasing matters. Doximity has operated without a permanent CFO long enough that its own securities filings have institutionalized the interim designation. A separate 8-K filed April 17, 2026 also disclosed an officer departure or appointment, making this the second leadership filing in six weeks when paired with the May 13 earnings 8-K. The company has not disclosed a permanent CFO in either filing.
Running a public company through an earnings cycle without a permanent financial officer is common in the short term. Extended across multiple quarters, the absence becomes a governance question. Investors expect a seated CFO for earnings calls and analyst dialogue, particularly when the stock is under pressure.
A Beat Record That Didn't Hold
Three consecutive EPS beats preceded this quarter: $0.36 against a $0.31 estimate, $0.45 against $0.38, and $0.46 against $0.45. A company with that track record would ordinarily receive the benefit of the doubt. The roughly 10% post-earnings decline suggests investors were reacting to something forward-looking rather than the historical beat streak, whether that was guidance, the leadership situation, or both.
SaaS platforms trade on forward estimates and multiple expansion, not trailing results. A stock that falls sharply on a quarter with a solid beat record is usually signaling that the guide disappointed.
The CEO's New Equity
Two days after the earnings filing, Jeffrey Tangney received a grant of 322,614 shares on May 15, 2026. On the same date, the company withheld shares for taxes at $18.01: 14,964 from Tangney's grant ($269,500) and 1,246 from Sitaram's ($22,400). The grant is a standard compensation mechanism, and receiving equity at post-correction prices creates genuine long-term alignment for a CEO who already holds a significant stake. A 322,614-share grant also adds to share count, a dilution consideration in a quarter where the stock has already repriced sharply lower.
What to Watch
Three items would shift this picture materially. A permanent CFO appointment would remove one of the cleaner near-term uncertainties and restore normal investor relations cadence. Any open-market insider buying, at any scale, would change the directional signal from the Form 4 record. And the next quarterly earnings report will clarify whether the forward guide embedded in the May 13 results was conservative or directionally accurate.
Three consecutive EPS beats suggest the underlying business model works. The CFO vacancy and the pre-earnings insider selling timeline are the friction points that prevent the picture from being straightforward. The evidence does not support a clean directional call in either direction. Run the free Doximity, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Why did Doximity stock fall after earnings?
DOCS fell roughly 10% in the session following its May 13 fiscal fourth-quarter earnings release, per Quiver Quantitative. The earnings 8-K also disclosed an officer-level change — the second such filing in six weeks — which appeared to compound investor concern beyond the headline numbers.
Does Doximity have a permanent CFO?
As of mid-May 2026, the CFO role remains unfilled. Siddharth Sitaram's Form 4 filings list his title as "Interim Principal Financial Officer and Principal Accounting Officer." Doximity filed two separate 8-Ks over six weeks disclosing officer-level changes without naming a permanent replacement in either.
Did Doximity insiders sell stock before the earnings drop?
Director Kira Scherer Wampler sold 9,000 shares at $26.06 on May 7, and Interim PFO Sitaram sold 2,309 shares at $25.77 on May 11, both before the post-earnings decline toward $18. Net insider activity over the prior 90 days shows $0.52 million in sales against zero open-market purchases.
Has Doximity been beating EPS estimates?
Yes, three consecutive quarters: $0.36 versus a $0.307 estimate, $0.45 versus $0.379, and $0.46 versus $0.447. The consistency of the beats suggests a management team setting achievable targets, though the 10% post-earnings selloff indicated investors were focused on factors beyond the bottom line.
What is the biggest risk to the Doximity investment thesis?
The most visible near-term risks are the unresolved CFO vacancy (two leadership disclosures in six weeks with no permanent appointment), consistent net insider selling with no open-market buying over 90 days, and the market's sharp repricing following an otherwise solid earnings report. A permanent CFO appointment is the clearest potential catalyst for a sentiment shift.